Breaking News
Friday , August 18 2017
Home / Tag Archives: Natco Pharma

Tag Archives: Natco Pharma

Natco Pharma reports around 3-fold jump in Q4 consolidated net profit

Natco Pharma has reported results for fourth quarter and year ended March 31, 2017. The company has reported has posted over 2-fold jump in its net profit after tax at Rs 177.30 crore for the quarter ended March 31, 2017 as compared to Rs 69 crore for the same quarter ... Read More »

Natco Pharma launches Hepatitis C drug Velpanat in India

Natco Pharma has launched a generic version of sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination in India. Sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination is sold by Gilead Sciences, globally, under the brand name Epclusa. Epclusa is the first all-oral, pan-genotypic, single tablet regimen ... Read More »